Deborah Schiff, M.D.

Bio

Dr. Deborah Schiff is an attending pediatric hematologist/oncologist at Rady Children's Hospital-San Diego and a clinical professor of pediatrics at UC San Diego School of Medicine. She is also medical director of the Hem/Oncology Palliative Care Program.

Dr. Schiff is board certified in both pediatric hematology/oncology and hospice & palliative medicine.

After receiving her medical degree from Brown Medical School, she completed her residency in pediatrics at Rhode Island Hospital/Brown Medical School, followed by a fellowship in pediatric hematology/oncology at Children's Hospital, Los Angeles.

Her clinical research primarily involves cancer clinical trials, outcomes in palliative medicine, and ethnic disparities in oncology. Dr. Schiff is an active member of Children's Oncology Group (COG) and has been principal investigator on numerous clinical trials. She has served as physician liaison for the St. Jude Children's Research Hospital/Rady Children's Alliance since 2007. Additionally, Dr. Schiff is an active member of the Rady Children's Stem Cell Transplant team.

Dr. Schiff has mentored many trainees, including UC San Diego medical students, residents and fellows, many of whom have presented their work at national meetings and published their findings in peer-reviewed journals.

Publications

Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Parekh D, Lin H, Batajoo A, Peckham-Gregory E, Karri V, Stanton W, Scull B, Fleishmann R, El-Mallawany N, Eckstein OS, Prudowsky ZD, Gulati N, Agrusa JE, Ahmed AZ, Chu R, Dietz MS, Goldman SC, Hogarty MD, Imran H, Intzes S, Kim JM, Kopp LM, Levy CF, Neff P, Pillai PM, Sisk BA, Schiff DE, Trobaugh-Lotrario AD, Walkovich K, McClain KL, Allen CE

Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia.
McNerney KO, Moskop A, Winestone LE, Baggott C, Talano JA, Schiff D, Rossoff J, Modi A, Verneris MR, Laetsch TW, Schultz L

Mediport use as an acceptable standard for CAR T cell infusion.
Eylon M, Prabhu S, John S, King MJM, Bhatt D, Curran KJ, Erickson C, Karras NA, Phillips CL, Satwani P, Hermiston M, Southworth E, Baumeister SHC, Talano JA, MacMillan ML, Rossoff J, Bonifant CL, Myers GD, Rouce RH, Toner K, Driscoll TA, Katsanis E, Salzberg DB, Schiff D, De Oliveira SN, Capitini CM, Pacenta HL, Pfeiffer T, Shah NC, Huynh V, Skiles JL, Fraint E, McNerney KO, Quigg TC, Krueger J, Ligon JA, Fabrizio VA, Baggott C, Laetsch TW, Schultz LM

Chronic active Epstein-Barr virus and hydroa vacciniforme-like lymphoproliferative disorder in a pediatric patient complicated by fatal ruptured cerebral artery aneurysm.
Yi T, Steinberg J, Olson S, El-Said H, Mo J, Anderson E, Gloude N, Schiff D

Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response.
Engel ER, Hammill A, Adams D, Phillips RJ, Jeng M, Tollefson MM, Iacobas I, Schiff D, Greenberger S, Kelly M, Frieden I, Zaghloul N, Drolet B, Geddis A, Goldenberg D, Ricci K

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.
Dávila Saldaña BJ, John T, Bonifant C, Buchbinder D, Chandra S, Chandrakasan S, Chang W, Chen L, Elfassy HL, Geerlinks AV, Giller RH, Goyal R, Hagin D, Islam S, Mallhi K, Miller HK, Owen W, Pacheco M, Patel NC, Querfeld C, Quigg T, Richard N, Schiff D, Shereck E, Stenger E, Jordan MB, Heslop HE, Bollard CM, Cohen JI

Tumor Genomic Profiling and Ex Vivo Drug Sensitivity Testing for Pediatric Leukemia and Lymphoma Patients.
Eaton A, Wong V, Schiff D, Anderson E, Ding H, Capparelli EV, Determan D, Kuo DJ

Irradiation-free RIC HSCT has a tolerable safety profile and is effective therapy for pediatric bone marrow failure syndromes.
Wang YM, Anderson E, Gloude N, Marion A, King C, Leung W, Schiff D

Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia.
Karol SE, Cooper TM, Mead PE, Crews KR, Panetta JC, Alexander TB, Taub JW, Lacayo NJ, Heym KM, Kuo DJ, Schiff DE, Bhojwani D, Ge Y, Klco JM, Ribeiro RC, Inaba H, Pui CH, Rubnitz JE

Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
Lauhan CR, Schiff D, Gloude N

Acute Megakaryoblastic Leukemia with Trisomy 21 and Tetrasomy 21 Clones in a Phenotypically Normal Child with Mosaic Trisomy 21.
Won E, Gruber TA, Tucker S, Schiff DE

Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial.
Rubnitz JE, Lacayo NJ, Inaba H, Heym K, Ribeiro RC, Taub J, McNeer J, Degar B, Schiff D, Yeoh AE, Coustan-Smith E, Wang L, Triplett B, Raimondi SC, Klco J, Choi J, Pounds S, Pui CH

Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.
Sarkar RR, Gloude NJ, Schiff D, Murphy JD

A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia.
Nguyen R, Wu H, Pounds S, Inaba H, Ribeiro RC, Cullins D, Rooney B, Bell T, Lacayo NJ, Heym K, Degar B, Schiff D, Janssen WE, Triplett B, Pui CH, Leung W, Rubnitz JE

CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
McClain KL, Picarsic J, Chakraborty R, Zinn D, Lin H, Abhyankar H, Scull B, Shih A, Lim KPH, Eckstein O, Lubega J, Peters TL, Olea W, Burke T, Ahmed N, Hicks MJ, Tran B, Jones J, Dauser R, Jeng M, Baiocchi R, Schiff D, Goldman S, Heym KM, Wilson H, Carcamo B, Kumar A, Rodriguez-Galindo C, Whipple NS, Campbell P, Murdoch G, Kofler J, Heales S, Malone M, Woltjer R, Quinn JF, Orchard P, Kruer MC, Jaffe R, Manz MG, Lira SA, Parsons DW, Merad M, Man TK, Allen CE

Encephalitis and Thalamic Injury From Neuroinvasive West Nile Virus in Children on Treatment for Acute Lymphoblastic Leukemia.
Farnaes L, Schiff D, McElroy AK, Coufal NG, Crawford JR, Cannavino C

A novel compound heterozygous form of severe protein C deficiency causing bleeding without purpura fulminans.
Herrick NL, Geddis AE, Lovejoy AE, Kim J, Schiff D, Thornburg CD

Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.
Navid F, Herzog CE, Sandoval J, Daryani VM, Stewart CF, Gattuso J, Mandrell B, Phipps S, Chemaitilly W, Sykes A, Davidoff AM, Shulkin BL, Bahrami A, Furman WL, Mao S, Wu J, Schiff D, Rao B, Pappo A

Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.
Aristizabal P, Singer J, Cooper R, Wells KJ, Nodora J, Milburn M, Gahagan S, Schiff DE, Martinez ME

Clinical outcomes of palliative radiation therapy for children.
Rahn DA 3rd, Mundt AJ, Murphy JD, Schiff D, Adams J, Murphy KT

Outcome of indwelling tunneled PleurX® catheter placement in pediatric and young adult patients with malignant effusions.
Adams J, Auger J, Schiff D

Hereditary intrinsic factor deficiency in chaldeans.
Sturm AC, Baack EC, Armstrong MB, Schiff D, Zia A, Savasan S, de la Chapelle A, Tanner SM

Insulin infusion to treat severe hypertriglyceridemia associated with pegaspargase therapy: a case report.
Lawson EB, Gottschalk M, Schiff DE

Palliative ventriculoperitoneal shunt in a pediatric patient with recurrent metastatic medulloblastoma.
Schiff D, Kline C, Meltzer H, Auger J

Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura.
Schiff DE, Roberts WD, Sue YJ

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.